Vir Biotechnology Appoints Suzanne Topalian to Board
Vir Biotechnology appointed Suzanne Topalian to its board of directors.
Related stories
KWAP Acquires 236,500 Inari Amertron Shares
M impact | EQUITY | Oct 29, 2026, 09:29 AM UTC
AVIC UAV Says Q3 Net Profit Rose 274.3% YoY
AVIC UAV said third-quarter net profit increased 274.3% year over year.
M impact | EQUITY | Oct 29, 2026, 09:29 AM UTC
EduSpec Holdings Reports Q2 Revenue of 14.59 Million RGT
M impact | EQUITY | Oct 29, 2026, 09:29 AM UTC
EduSpec Holdings Reports Q2 Loss of RGT 135,000
EduSpec Holdings reported a Q2 loss attributable to equity holders of RGT 135,000.
M impact | EQUITY | Oct 29, 2026, 09:29 AM UTC
Linde reports Q3 revenue of $9.4 billion
M impact | EQUITY | Oct 29, 2026, 09:29 AM UTC
Eduspec Holdings Reports Second-Quarter 2026 Results
Revenue was MYR 14.593 million, compared with MYR 12.733 million a year earlier. Pretax profit was negative in both periods.
M impact | EQUITY | Oct 29, 2026, 09:28 AM UTC